A co‐formulation of pramlintide and insulin <scp>A21G</scp> ( <scp>ADO09</scp> ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes

Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You‐Ping Chan, Olivier Soula, Matthew Riddle

Open source

DOI: 10.1111/dom.14972
Published: 2023-01-31
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.14972,
  title = {A co‐formulation of pramlintide and insulin
                    <scp>A21G</scp>
                    (
                    <scp>ADO09</scp>
                    ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes},
  author = {Grit Andersen and Rosy Eloy and Susanne Famulla and Tim Heise and Grégory Meiffren and Cyril Seroussi and Martin Gaudier and Claire Mégret and You‐Ping Chan and Olivier Soula and Matthew Riddle},
  year = {2023},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.14972},
  url = {https://doi.org/10.1111/dom.14972}
}

RIS

TY  - JOUR
TI  - A co‐formulation of pramlintide and insulin
                    <scp>A21G</scp>
                    (
                    <scp>ADO09</scp>
                    ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes
AU  - Grit Andersen
AU  - Rosy Eloy
AU  - Susanne Famulla
AU  - Tim Heise
AU  - Grégory Meiffren
AU  - Cyril Seroussi
AU  - Martin Gaudier
AU  - Claire Mégret
AU  - You‐Ping Chan
AU  - Olivier Soula
AU  - Matthew Riddle
PY  - 2023
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.14972
UR  - https://doi.org/10.1111/dom.14972
ER  -

APA

Andersen, G., Eloy, R., Famulla, S., Heise, T., Meiffren, G., Seroussi, C., Gaudier, M., Mégret, C., Chan, Y., Soula, O., & Riddle, M. (2023). A co‐formulation of pramlintide and insulin <scp>A21G</scp> ( <scp>ADO09</scp> ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14972

Source records

crossref · retrieved 2026-09-26T12:41:20.624Z